Skip to main content
Intermediate Technical IVT

Cas9

Pronunciation: kaz-NINE

Also written as: Cas9 — CRISPR-associated protein 9

An RNA-guided endonuclease that creates double-strand breaks at targeted genomic loci; the most widely used nuclease in CRISPR-based editing. Rendered as 'Cas9', not 'CAS9' or 'cas9'.

Full Definition

Cas9 is a CRISPR-associated endonuclease derived from Streptococcus pyogenes (SpCas9) that acts as the 'molecular scissors' of the CRISPR-Cas9 system. It is directed to a specific DNA sequence by a guide RNA (gRNA) and introduces a double-strand break, triggering cellular repair mechanisms. Editors should note the mixed-case convention: 'Cas9', not 'CAS9', 'cas9', or 'Cas-9'. When the organism of origin is specified, the convention is SpCas9 (from S. pyogenes) or SaCas9 (from S. aureus). The gene encoding the protein is italicised in lower case: cas9.

Usage

Usage note: Mixed case is mandatory: 'Cas9'. The gene name is italicised and lowercased: *cas9*. Distinguish from Cas12a and Cas13, which have distinct mechanisms.

In Context

  • "The author had written 'CAS9' throughout; this was corrected to 'Cas9' in line with standard nomenclature." — Copy-editing note
  • "SpCas9 was delivered as a ribonucleoprotein complex to reduce off-target effects." — Methods section

Also known as

CRISPR-associated protein 9 SpCas9

Don't confuse with

Cas12a Cas13 dCas9 nCas9

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON